Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by Lvlchange on Mar 13, 2024 9:40am

LABS

Just needs to make money, or we lose all ours and someone else picks up the pieces.  


If this happens, or that happens, I'm getting sick of it.  Just make money.

Comment by Starkicker on Mar 13, 2024 11:32am
A lot of distracting speculation on here for sure. Earnings report at the end of this month will be very telling. I',ll be very disappointed if Q1 earnings are under $20M after the last report teaser about EPS being positive lin Q4 2023.
Comment by subaru1 on Mar 13, 2024 12:09pm
Starkicker, i agree with you a lot of distractions here. Earning report will be out soon, you mention earning of $20m, i supposed that you mean revenue of $20m which i beleive will be under $10m for the 4qrt in my case and earning at $0,00. 2024 is still a very uncertain case. The way they handle the relarion with the investors is so bad it is hard to make us an idea of the future. Speculator here ...more  
Comment by Starkicker on Mar 13, 2024 1:06pm
Definitely no BIG NEWS coming here. Pfizer is not the partner, DEA probably won't approve as Schedule 3, and FDA has aleady approved LSD as a Breakthrough Therapy Drug for anxiety before cannabis gets approved., if ever. Germany is a bright spot with 220,000 medical cannabis patients but that market will take time. The reality is LABS is where it's at for a reason and it won't vhange ...more  
Comment by Lvlchange on Mar 13, 2024 1:27pm
Cheers guys.  This board something me is like pulling up to a pub at 1pm with a bunch of alcoholics.   All you hear is a bunch of gonna do this, I wanna do this... but nothing has been done.  The plan sounds great... awesome...  LABS needs to make money period.  Some of the certifications are excellent, I just home we have enough cash to see them in action under the ...more  
Comment by Starkicker on Mar 13, 2024 1:37pm
Once you put the guy who's financial advisor is quantum space dust and alleyesonme on ignore, the picture becomes much clearer.
Comment by Lvlchange on Mar 13, 2024 1:48pm
LOL :-)
Comment by subaru1 on Mar 13, 2024 2:05pm
Real finance number will speak loud by the end of the month if they are better than expected by the majority if not we will be a $0,06 for a while again. Don't forget Labs is dead money since 2 years and has been on a downtrend since over 4 years. A lot of retail investors are unhappy here. We are all here to make money not to speculate which who they do business and waiting to a miracle.
Comment by subaru1 on Mar 13, 2024 1:29pm
Remember 3qrt sale were only $8,5 millions.
Comment by Redwine12345 on Mar 13, 2024 1:24pm
Too many people got married to this stock and they are praising the marriage. Market maker on another hand doesn't give a sh*t about marriage. They are more concerned with fair market value and what they can get out of this marriage. Having said that, you still have to read between the lines. I.e., almost 200K traded today. And yet, the size of the bid is almost the same as it was at the ...more  
Comment by Solid1 on Mar 13, 2024 2:43pm
Yes, it was love at first sight 
Comment by Lemoyne on Mar 13, 2024 10:18pm
There was no such teaser. Their guidance was as such, MD&A Q1 2023:positive EBITDA and cash flow by first half 2024 MD&A Q2 2023: they removed any guidance because of uncertainty surrounding VIVO integration and restructuring costs taking more time and cash than anticipated. MD&A Q3 2023: they guided for positive EBITDA and cashflow "in 2024" your hopes for Q1 20m revs ...more  
Comment by subaru1i on Mar 14, 2024 8:46am
So unless you know the future, you too are betting that there will be no surprise from Q4, 2023.  And to correct you, CEO anticipated by his comments that Q1, 2024 would be their first profitable quarter.   Footnote: Health Canada approves Epidiolex late 2023.   
Comment by Lemoyne on Mar 14, 2024 10:29am
Nope, CEO never mentioned Q1 2024 specifically. And you're about to wake up from your dream about LABS surprising you in Q4 2023. I doubt revs go above 10M in Q42023. And even if they did, there would be no profitability. There is still gonna be cash burn and a negative EBITDA.
Comment by subaru1i on Mar 14, 2024 11:29am
Time will tell because Time and life experience always reveals the Truth π.   
Comment by okgonow on Mar 14, 2024 12:08pm
WoW...! you are a Guru!!! Thats sooooooo deep how bout this one: "We are all born ignorant, but one must work hard to remain stupid." No Coolaide for me ..
Comment by Lemoyne on Mar 14, 2024 4:45pm
Not sure I agree with that. But what is clear is YOU are not telling the truth.
Comment by subaru1i on Mar 14, 2024 5:18pm
I'm not going to argue with you, CEO stated Q1, 2024 is their target for profitability.   I have no motive in lying.  I laid my claim in LABS with over 1.5 million shares as a long term shareholder.   
Comment by Lvlchange on Mar 14, 2024 10:59pm
So yer admitting to being a pumper because of your investment.   Get on board... LABS success will be based on making money and not speculation.   LABS, needs to make money.   say it
Comment by mdjbrown on Mar 14, 2024 11:13pm
s1i, keep the faith..... Lots of interesting personalities appearing here lately eager to argue, but as you say, time will tell! Is that timeline Q1, Q2, or Q3?   Guess we have to wait to find out........ There must be something going on behind the scenes, as AVCN continues to climb while Mr Pidduck prefers to stay invisible
Comment by Lemoyne on Mar 15, 2024 12:16am
There's no arguing because you have no proof CEO said Q1 profitability. Period.
Comment by subaru1 on Mar 14, 2024 2:37pm
After telling us for years that a BIG news is coming he tells us that he doesn't know the future WOW what a surprise.
Comment by Starkicker on Mar 14, 2024 10:09am
I don't know about a world of hurt and disappointment...lol.  What a weird comment. Anyway, if you listen to the last earnings report at around the 28 minute mark if I recall, they do indicate positive cash flow as early as Q4 2023 and definitely by Q1 2024. 
Comment by Lemoyne on Mar 14, 2024 10:22am
Nope they don't. I've listened multiple times to that cc and read the transcript. Nothing of the sort.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities